相关实验视频
Updated: Jun 11, 2025

13:07
A Protocol for Transcranial Photobiomodulation Therapy in Mice
Published on: November 18, 2018
12.1K
光生物调节调节天体细胞活动,并改善斯科波胺诱导的认知行为衰退
Ji On Park1, Namgue Hong2, Min Young Lee3
1Department of Medical Laser, Graduate School of Medicine, Dankook University, Cheonan-si, Republic of Korea.
Frontiers in cellular neuroscience
|October 7, 2024
概括
光生物调制 (PBM) 可能改善认知衰退并减少阿尔茨海默氏症的神经元死亡.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 细胞生物学 细胞生物学
背景情况:
- 阿尔茨海默病 (AD) 的病理生理学仍然不清楚,没有确定的治疗方法.
- 斯科波胺诱导AD类症状,包括记忆力缺陷和神经炎症.
- 星球细胞被认为是潜在的AD生物标志物.
研究的目的:
- 在阿尔茨海默病模型中研究光生物调制 (PBM) 的治疗潜力.
- 评估PBM对认知功能,神经元存活率和星球细胞活动的影响.
- 探索PBM的潜在机制,包括MAPK路径.
主要方法:
- 动物中的斯科波胺诱导的记忆功能障碍模型.
- 使用825nm近红外光进行光生物调制 (PBM).
- 行为测试 (莫里斯水迷宫,Y迷宫),海马体组织学和天体细胞标记物和MAPK通路的免疫光学.
主要成果:
- 在海马体中,PBM显著降低了斯科波胺诱导的神经细胞死亡.
- PBM改变了线粒激活蛋白激酶 (MAPK) 路径标记物和状纤维酸蛋白 (GFAP) 表达.
- 功能和组织学结局显示出显著的相关性,验证了PBM的疗效.
结论:
- 光生物调制 (PBM) 在AD模型中显示了改善认知和组织学缺陷的潜力.
- PBM的治疗效果可能涉及神经炎症和天体细胞活动的调节.
- 这项研究强调了PBM作为一种有希望的非侵入性治疗策略,用于AD等神经退行性疾病.
更多相关视频
06:56Near Infrared NIr Light Increases Expression of a Marker of Mitochondrial Function in the Mouse Vestibular Sensory Epithelium
Published on: March 14, 2015
9.9K
07:56Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases
Published on: June 28, 2024
652
相关概念视频
Brain Imaging
216
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
216
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
106
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
106